Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 1, 2016, Pages 60-68

  Schwanekamp, Jennifer A ^a   Lorts, Angela ^a   Vagnozzi, Ronald J ^a   Vanhoutte, Davy ^a   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

apolipoproteins E; atherosclerosis; extracellular matrix; periostin

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; MESSENGER RNA; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; CELL ADHESION MOLECULE; POSTN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; EXPERIMENTAL INFLAMMATION; EXTRACELLULAR MATRIX; GENE DELETION; INFLAMMATORY CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEPLETION; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTIC DISEASES; ATHEROSCLEROSIS; C57BL MOUSE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; THORACIC AORTA; TIME FACTOR; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR REMODELING;

EID: 84952637411     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306397     Document Type: Article

References (52)

1. Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012 125 e2 e220. doi: 10.1161/CIR.0b013e31823ac046
2. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP, Collagens in the progression and complications of atherosclerosis. Vasc Med 2009 14 73 89. doi: 10.1177/1358863X08094801
3. Rudijanto A, The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007 39 86 93
4. Norris RA, Damon B, Mironov V, Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007 101 695 711. doi: 10.1002/jcb.21224
5. Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L, Firulli AB, Molkentin JD, Markwald R, Conway SJ, Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res 2008 102 752 760. doi: 10.1161/CIRCRESAHA.107.159517
6. Ostriker A, Horita HN, Poczobutt J, Weiser-Evans MC, Nemenoff RA, Vascular smooth muscle cell-derived transforming growth factor-beta promotes maturation of activated, neointima lesion-like macrophages. Arterioscler Thromb Vasc Biol 2014 34 4 877 886. doi: 10.1161/ATVBAHA.114.303214
7. Frutkin AD, Otsuka G, Stempien-Otero A, Tgf-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein e-null mice. Arterioscler Thromb Vasc Biol 2009 29 1251 1257. doi: 10.1161/ATVBAHA.109.186593
8. Newby AC, Zaltsman AB, Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 1999 41 345 360
9. Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P, Aikawa M, Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005 112 2708 2715. doi: 10.1161/CIRCULATIONAHA.105.562041
10. Jones CB, Sane DC, Herrington DM, Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003 59 812 823
11. Sasaki T, Nakamura K, Sasada K, Okada S, Cheng XW, Suzuki T, Murohara T, Sato K, Kuzuya M, Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice. Atherosclerosis 2013 227 43 50. doi: 10.1016/j.atherosclerosis.2012.12.008
12. Sternlicht MD, Bissell MJ, Werb Z, The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000 19 1102 1113. doi: 10.1038/sj.onc.1203347
13. Silence J, Lupu F, Collen D, Lijnen HR, Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001 21 1440 1445
14. Galis ZS, Sukhova GK, Lark MW, Libby P, Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994 94 2493 2503. doi: 10.1172/JCI117619
15. Zinn K, McAllister L, Goodman CS, Sequence analysis and neuronal expression of fasciclin I in grasshopper and Drosophila. Cell 1988 53 577 587
16. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A, Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999 14 1239 1249. doi: 10.1359/jbmr.1999.14.7.1239
17. Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, Okada Y, Yozu R, Shukunami C, Hiraki Y, Kudo A, Ogawa S, Fukuda K, Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest 2010 120 2292 2306. doi: 10.1172/JCI40973
18. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD, Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007 101 313 321. doi: 10.1161/CIRCRESAHA.107.149047
19. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A, Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 2008 205 295 303. doi: 10.1084/jem.20071297
20. Minicucci MF, Santos PP, Rafacho BP, Gonçalves AF, Ardisson LP, Batista DF, Azevedo PS, Polegato BF, Okoshi K, Pereira EJ, Paiva SA, Zornoff LA, Periostin as a modulator of chronic cardiac remodeling after myocardial infarction. Clinics (Sao Paulo) 2013 68 1344 1349. doi: 10.6061/clinics/2013(10)09
21. Lindsley A, Li W, Wang J, Maeda N, Rogers R, Conway SJ, Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene Expr Patterns 2005 5 593 600. doi: 10.1016/j.modgep.2005.03.005
22. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP, Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005 25 77 83. doi: 10.1161/01.ATV.0000149141.81230.c6
23. Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK, Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007 6 1088 1102. doi: 10.1074/mcp.M600259-MCP200
24. Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S, Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 2015 17 170 182. doi: 10.1038/ncb3090
25. Bobryshev YV, Killingsworth MC, Huynh TG, Lord RS, Grabs AJ, Valenzuela SM, Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin? Basic Res Cardiol 2007 102 133 143. doi: 10.1007/s00395-006-0637-9
26. Li AC, Glass CK, The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002 8 1235 1242. doi: 10.1038/nm1102-1235
27. Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, Tan H, Hoffman S, Hart MM, Kern MJ, Damon B, Markwald RR, Goodwin RL, Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009 238 1052 1063. doi: 10.1002/dvdy.21933
28. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ, Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001 103 183 188
29. Reddick RL, Zhang SH, Maeda N, Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994 14 141 147
30. Johnson JL, Devel L, Czarny B, George SJ, Jackson CL, Rogakos V, Beau F, Yiotakis A, Newby AC, Dive V, A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol 2011 31 528 535. doi: 10.1161/ATVBAHA.110.219147
31. Quillard T, Tesmenitsky Y, Croce K, Travers R, Shvartz E, Koskinas KC, Sukhova GK, Aikawa E, Aikawa M, Libby P, Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arterioscler Thromb Vasc Biol 2011 31 2464 2472. doi: 10.1161/ATVBAHA.111.231563
32. Wågsäter D, Paloschi V, Hanemaaijer R, Hultenby K, Bank RA, Franco-Cereceda A, Lindeman JH, Eriksson P, Impaired collagen biosynthesis and cross-linking in aorta of patients with bicuspid aortic valve. J Am Heart Assoc 2013 2 e000034. doi: 10.1161/JAHA.112.000034
33. Moussallem MD, Olenych SG, Scott SL, Keller TC 3rd, Schlenoff JB, Smooth muscle cell phenotype modulation and contraction on native and cross-linked polyelectrolyte multilayers. Biomacromolecules 2009 10 3062 3068. doi: 10.1021/bm9007309
34. Vukovic I, Arsenijevic N, Lackovic V, Todorovic V, The origin and differentiation potential of smooth muscle cells in coronary atherosclerosis. Exp Clin Cardiol 2006 11 123 128
35. Lagraauw HM, Westra MM, Bot M, Wezel A, van Santbrink PJ, Pasterkamp G, Biessen EA, Kuiper J, Bot I, Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation. Atherosclerosis 2014 235 196 203. doi: 10.1016/j.atherosclerosis.2014.04.025
36. Merched A, Tollefson K, Chan L, Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice. Cardiovasc Res 2010 85 853 863. doi: 10.1093/cvr/cvp347
37. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Taniguchi S, Takahashi M, Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2012 425 162 168. doi: 10.1016/j.bbrc.2012.07.058
38. Lorts A, Schwanekamp JA, Baudino TA, McNally EM, Molkentin JD, Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway. Proc Natl Acad Sci USA 2012 109 10978 10983. doi: 10.1073/pnas.1204708109
39. Hixson JE, Shimmin LC, Montasser ME, Kim DK, Zhong Y, Ibarguen H, Follis J, Malcom G, Strong J, Howard T, Langefeld C, Liu Y, Rotter JI, Johnson C, Herrington D, Common variants in the periostin gene influence development of atherosclerosis in young persons. Arterioscler Thromb Vasc Biol 2011 31 1661 1667. doi: 10.1161/ATVBAHA.111.224352
40. Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A, Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 2010 285 2028 2039. doi: 10.1074/jbc.M109.051961
41. Elliott CG, Wang J, Guo X, Xu SW, Eastwood M, Guan J, Leask A, Conway SJ, Hamilton DW, Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci 2012 125 Pt 1 121 132. doi: 10.1242/jcs.087841
42. Johnson JL, George SJ, Newby AC, Jackson CL, Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 2005 102 15575 15580. doi: 10.1073/pnas.0506201102
43. Li G, Jin R, Norris RA, Zhang L, Yu S, Wu F, Markwald RR, Nanda A, Conway SJ, Smyth SS, Granger DN, Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010 208 358 365. doi: 10.1016/j.atherosclerosis.2009.07.046
44. Li W, Gao P, Zhi Y, Xu W, Wu Y, Yin J, Zhang J, Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res 2015 16 57. doi: 10.1186/s12931-015-0218-2
45. Masuoka M, Shiraishi H, Ohta S, Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012 122 2590 2600. doi: 10.1172/JCI58978
46. Hatsukami TS, Ross R, Polissar NL, Yuan C, Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000 102 959 964
47. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V, Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995 92 1565 1569
48. van der Wal AC, Becker AE, Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc Res 1999 41 334 344
49. McCaffrey TA, TGF-beta signaling in atherosclerosis and restenosis. Front Biosci (Schol Ed) 2009 1 236 245
50. Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR, Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995 92 2995 3005
51. Moore KJ, Tabas I, Macrophages in the pathogenesis of atherosclerosis. Cell 2011 145 341 355. doi: 10.1016/j.cell.2011.04.005
52. Majesky MW, Mouse model for atherosclerotic plaque rupture. Circulation 2002 105 2010 2011